[596] Helicobacter Pylori Infection Is Associated with an Increase in the Stem Cell Population in Gastric Mucosa
Q Ahmed, R Tawil, P Sochacki, N Khoury, J Du, B Patel, AP Majumdar, E Levi. Wayne State University, Detroit, MI; Karmanos Cancer Institute, Detroit, MI; John D. Dingell VAMC, Detroit, MI
Background: Evidence supporting a causal relationship between gastric dysplasia, carcinoma and Helicobacter pylori (HP) infection has been demonstrated previously. Growing evidence firmly supports that Cancer stem cells (CSCs) exist in a wide array of solid tumors. However the presence and origin of these CSCs in gastric cancer remains to be elucidated. We conducted a pilot study at our institution to possibly identify these CSCs by immunohistochemical (IHC) markers, in precursor lesions of gastric cancer, including early events such as HP gastritis.
Design: Gastric biopsies and resection specimens representing normal (n=10), HP without intestinal metaplasia (IM) (n=12), HP with IM (n=10) and gastric adenocarcinoma (n=12) were identified. These cases were evaluated for stem cell markers CD166, ALDH1 and LGR5 by IHC. We defined positivity in normal and HP cases as membranous and cytoplasmic staining in number of cells per gland (CPG). For cancer cases we used percentage of tumor cells to define positivity. Statistical significance was assessed by Chi Square test.
Results: Of the normal cases 8 /10 showed 1-2 CPG positive for ALDH1, 10/10 showed 1-2 CPG positive for LGR5, however CD166 did not stain any glandular cells. 12/12 cases of HP without IM showed 5-6 CPG positive for ALDH1, 4-5 CPG positive for CD166 and 4-5 CPG positive for LGR5. 10/10 cases of HP with IM showed 7-8 CPG positive for ALDH1, 5-6 CPG positive for CD166 and LGR5. Of the 12 cancer cases 85% were positive for ALDH1, 75% were positive for CD166 and 70% were positive for LGR5. The level of positivity ranged from 5 to 40% of the tumor cells. Staining was more prominent in the invasive fronts and lymph node metastases.
| n | ALDH1 | CD166 | LGR5 | |
| Normal | 10 | 1-2 | 0 | 1-2 |
| HP without IM | 12 | 5-6* | 4-5* | 4-5* |
| HP with IM | 10 | 7-8* | 5-6* | 5-6* |
| Gastric adenocarcinoma | 12 | 85% | 75% | 70% |